Biomarkers of inflammation in cattle determining the effectiveness of anti-inflammatory drugs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 33, Issue 1, 2010, Pages 1-8

  Myers, M J ^a   Scott, M L ^a   Deaver, C M ^a   Farrell, D E ^a   Yancy, H F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 PHENYL 3 (TRIFLUOROMETHYL) 1H PYRAZOL YL]BENZENESULFONAMIDE; ACETYLSALICYLIC ACID; BENZENESULFONAMIDE DERIVATIVE; BIOLOGICAL MARKER; BRADYKININ; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; FLUNIXIN MEGLUMINE; INDOMETACIN; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD CULTURE; CATTLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; IN VITRO STUDY; INFLAMMATION; LACTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CATTLE; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; RNA, MESSENGER;

BOS; BOVINAE; MAMMALIA;

EID: 76749096808     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2009.01096.x     Document Type: Article

References (33)

1. Anonymous (1998) Supplemental New Animal Drug Application for NADA 101-479 for beef cattle and non-lactating diary cattle for claim to treat inflammation in endotoxemia. Available at: http://www.fda.gov/cvm/FOI/101- 479s050598.pdf accessed 10 November 2008.
2. Anonymous (2004) Supplemental New Animal Drug Application for NADA 101-479 for diary cattle for claim to treat inflammation. Available at: http://www.fda.gov/cvm/FOI/101479s081904.pdf accessed 10 November 2008.
3. Anonymous (2008) Development of target animal safety and effectiveness data to support approval of non-steroidal anti-inflammatory drugs (NSAIDs) for use in animals. http://www.fda.gov/cvm/Guidance/guide123.doc accessed 25 November 2008.
4. Blain, H., Boileau, C., Lapicque, F., Nédélec, E., Loeuille, D., Guillaume, C., Gaucher, A., Jeandel, C., Netter, P. Jouzeau, J.Y. (2002) Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. British Journal Clinical Pharmacology, 53, 255 265.
5. Brooks, P., Emery, P., Evans, J.F., Fenner, H., Hawkey, C.J., Patrono, C., Smolen, J., Breedveld, F., Day, R., Dougados, M., Ehrich, E.W., Gijon-Baños, J., Kvien, T.K., Van Rijswijk, M.H., Warner, T. Zeidler, H. (1999) Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology, 38, 779 788.
6. Bryant, C.E., Farnfield, B.A. Janicke, H.J. (2003) Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. American Journal Veterinary Research, 64, 211 216.
7. FitzGerald, G.A., Pedersen, A.K. Patrono, C. (1983) Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation, 67, 1174 1177.
8. Hecker, K.H. Roux, K.H. (1996) High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. BioTechniques, 20, 478 485.
9. Inoue, H., Umesono, K., Nishimori, T., Hirata, Y. Tanabe, T. (1983) Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochemical Biophysical Research Communications, 254, 292 298.
10. Joussen, A.M., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S. Adamis, A.P. (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB Journal, 16, 438 440.
11. Kiku, Y., Matsuzawa, H., Ohtsuka, H., Terasaki, N., Fukuda, S., Kon-Nai, S., Koiwa, M., Yokomizo, Y., Sato, H., Rosol, T.J., Okada, H. Yoshino, T.O. (2002) Effects of chlorpromazine, pentoxifylline and dexamethasone on mRNA expression of lipopolysaccharide-induced inflammatory cytokines in bovine peripheral blood mononuclear cells. Journal Veterinary Medical Science, 64, 723 726.
12. Koop, E. Sankar, G. (1994) Inhibition of NF-κβ by sodium salicylate and aspirin. Science, 265, 956 959.
13. Matsumoto, H., Naraba, H., Murakami, M., Kudo, I., Yamaki, K., Ueno, A. Oh-ishi, S. (1997) Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochemical Biophysical Research Communications, 230, 110 114.
14. Mortaz, E., Redegeld, F.A., Nijkamp, F.P. Engels, F. (2005) Dual effects of acetylsalicylic acid on mast cell degranulation, expression of cyclooxygenase-2 and release of pro-inflammatory cytokines. Biochemical Pharmacology, 69, 1049 1057.
15. Murakami, M. Kudo, I. (2004) Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Progress Lipid Research, 43, 3 35.
16. Nakamura, T. Sakamoto, K. (2001) Reactive oxygen species up-regulates cyclooxygenase-2, p53, and BAX mRNA expression in bovine luteal cells. Biochemical Biophysical Research Communications, 284, 203 210.
17. Naraba, H., Murakami, M., Matsumoto, H., Shimbara, S., Ueno, A., Kudo, I. Oh-ishi, S. (1998) Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. Journal Immunology, 160, 2974 2982.
18. Nichols, F.C., Garrison, S.W. Davis, H.W. (1988) Prostaglandin E2 and thromboxane B2 release from human monocytes treated with bacterial lipopolysaccharide. Journal Leukocyte Biology, 44, 376 384.
19. Oonishi, T., Sakashita, K., Ishioka, N., Suematsu, N., Shio, H. Uyesaka, N. (1998) Production of prostaglandins E1 and E2 by adult human red blood cells. Prostaglandins Other Lipid Mediators, 56, 89 101.
20. Panara, M.R., Padovano, R., Sciulli, M.G., Santini, G., Renda, G., Rotondo, M.T., Pace, A., Patrono, C. Patrignani, P. (1998) Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings. Clinical Pharmacology Therapeutics, 63, 672 681.
21. Patrignani, P., Panara, M.R., Sciulli, M.G., Santini, G., Renda, G. Patrono, C. (1997) Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. Journal Physiological Pharmacology, 48, 623 631.
22. Penning, T.D., Talley, J.J., Bertenshaw, S.R., Carter, J.S., Collins, P.W., Docter, S., Graneto, M.J., Lee, L.F., Malecha, J.W., Miyashiro, J.M., Rogers, R.S., Rogier, D.J., Yu, S.S., Anderson, G.D., Burton, E.G., Cogburn, J.N., Gregory, S.A., Koboldt, C.M., Perkins, W.E., Seibert, K., Veenhuizen, A.W., Zhang, Y.Y. Isakson, P.C. (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). Journal Medicinal Chemistry, 40, 1347 1365.
23. Samuelsson, B. (1991) Arachidonic acid metabolism: role in inflammation. Zeitschrift für Rheumatologie, 50 (Suppl. 1 3 6.
24. Serhan, C.N. Levy, B. (2003) Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Proceedings National Academy Science, 100, 8609 8611.
25. Shackelford, R.E., Alford, P.B., Xue, Y., Thai, S.F., Adams, D.O. Pizzo, S. (1997) Aspirin inhibits tumor necrosis factor-alpha gene expression in murine tissue macrophages. Molecular Pharmacology, 52, 421 429. (Pubitemid 27412967)
26. Taylor, B.C., Keefer, R.G., Deller, J.D., Nakamura, Y., Cullor, J.S. Stott, J.L. (1997) T cell populations and cytokine expression in milk derived from normal and bacteria-infected bovine mammary glands. Cellular Immunology, 182, 68 76.
27. Tegeder, I., Lötsch, J., Krebs, S., Muth-Selbach, U., Brune, K. Geisslinger, G. (1999) Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. Clinical Pharmacology Therapeutics, 65, 533 544.
28. Tilley, S.L., Coffman, T.M. Koller, B.H. (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. Journal Clinical Investigation, 108, 15 23.
29. Warner, T.D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J.A. Vane, J.R. (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings National Academy Science, 96, 7563 7568.
30. Xu, X.-M., Sansores-Garcia, L., Chen, X.-M., Mathijevic-Aleksic, N., Du, M. Wu, K.K. (1999) Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proceedings National Academy Science, 96, 5292 5297.
31. Yancy, H.F., Ayers, S.L., Farrell, D.E., Day, A. Myers, M.J. (2001) Differential cytokine mRNA expression in swine whole blood and peripheral blood mononuclear cell cultures. Veterinary Immunology Immunopathology, 79, 41 52.
32. Yaqoob, P. Calder, P. (1995) Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cellular Immunology, 163, 120 128.
33. Yuan, C.-J., Mandal, A.K., Zhang, Z. Mukherjee, A.B. (2000) Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs. Cancer Research, 60, 1084 1091.